Clariant acquires Oberhausen Technology Center (OTC)
Acquisition is part of company strategy to develop and strengthen ICS portfolio
OTC is a privately owned company, providing formulation expertise to transform new sustainable and innovative technologies into cost efficient consumer products. OTC has a leading position in development of delivery technologies for micronized active ingredients, which offer customers in consumer care markets innovative solutions in cosmetic, food or other application areas.
Michael Willome, Head of Clariant’s ICS Business Unit, says the deal fits perfectly with Clariant’s strategy of gaining strong positions in new and rapidly developing fields. “OTC gives us an entry into advanced delivery systems for actives and provides us with access to innovative formulation technologies, complementing our own portfolio. That will allow our customers to further differentiate their portfolio and service offerings.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.